Diana J. Pillas
Johns Hopkins University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Diana J. Pillas.
Epilepsia | 2006
Eric H. Kossoff; Jane R. McGrogan; Renee M. Bluml; Diana J. Pillas; James E. Rubenstein; Eileen P. G. Vining
Summary: Purpose: The Atkins diet may induce ketosis as does the ketogenic diet, without restrictions on calories, fluids, protein, or need for an inpatient fast and admission. Our objective was to evaluate the efficacy and tolerability of a modified Atkins diet for intractable childhood epilepsy.
Neurology | 2003
Eric H. Kossoff; Eileen P. G. Vining; Diana J. Pillas; Paula L. Pyzik; Anthony M. Avellino; Benjamin S. Carson; John M. Freeman
Background: Surgical removal of one hemisphere has been performed for several decades to treat intractable unihemispheric epilepsy. A prior case series focused on the outcomes after 58 surgeries at Johns Hopkins Hospital in 1997. This series, and an additional 53 cases, were reviewed to bring the outcomes up to date. Methods: Charts of the 111 patients undergoing hemidecortications at the Pediatric Epilepsy Center from 1975 to 2001 were reviewed and families were contacted. Three children died in the immediate perioperative period and three were lost to follow-up immediately after surgery. Follow-up ranged from 3 months to 22 years. Results: Two children died several years later due to intractable seizures. Overall, 65% are seizure-free, 21% have occasional, non-handicapping seizures, and 14% have troublesome seizures. Eighty percent are on one anticonvulsant or none and 89% are able to walk without assistance. Etiology strongly predicted seizure outcome. Patients with migrational disorders are less likely to be seizure-free than all other etiologies (predominantly Rasmussen and congenital vascular injuries) combined (51% vs 71%, p = 0.05). Conclusions: Hemidecortication continues to be a beneficial procedure in reducing seizure frequency in cases of unilateral cortical epilepsy. Fewer children with migrational disorders are seizure-free.
Epilepsy & Behavior | 2006
Sharifeh Farasat; Eric H. Kossoff; Diana J. Pillas; James E. Rubenstein; Eileen P. G. Vining; John M. Freeman
Although the success rates and complications of various treatment options for children with intractable epilepsy have been described, the actual expectations of parents for these treatments are less clear. Since 1998, parents at our institution have written their goals in a letter before starting their children on the ketogenic diet. One hundred consecutive letters were evaluated. The most common first goal was seizure improvement, second was anticonvulsant reduction, and third was cognitive improvement. Ninety percent requested improvement in cognition or alertness. These expectations were either met or exceeded at 6 months in 52-60% of children. Achieving or surpassing parental expectations for cognitive improvement correlated with longer diet duration (P=0.04), but meeting goals for seizure or anticonvulsant reduction did not. Cognitive improvement (P<0.001) and >90% seizure reduction (P=0.04) at 6 months positively correlated with longer eventual diet duration. Expectations for cognitive improvement need to be discussed prior to beginning the ketogenic diet.
Journal of Neuroscience Nursing | 1999
Jane Cassilly Casey; Jane R. McGrogan; Diana J. Pillas; Paula L. Pyzik; John M. Freeman; Eileen P. G. Vining
The Ketogenic Diet is an effective treatment for epilepsy in children. At Johns Hopkins Hospital more than 400 children have been placed on the Ketogenic Diet. The implementation and maintenance of this treatment require significant collaboration between the family and Epilepsy Team. During initiation of the diet, in the hospital, parents attend classes on the history and mechanism of the diet, preparation of meals, psychological issues, complications and the management of childhood illnesses on the ketogenic diet. Many factors are considered in calculating a ketogenic formula. Age, weight, height and activity level are the obvious factors. However, secondary medical diagnoses, medications, neurological deficits, feeding issues and psychological issues are additional factors that affect the formulation of an optimal ketogenic prescription. Once this prescription has been formulated and implemented, many patients require fine-tuning of their ketogenic diets to get the best antiepileptic results while promoting growth. We believe that our success in sustaining this treatment is related to our fine-tuning and management practices.
Pediatrics | 1998
John M. Freeman; Eileen P. G. Vining; Diana J. Pillas; Paula L. Pyzik; Jane Cassilly Casey; L. a. M. T. Kelly
Pediatrics | 1997
Eileen P. G. Vining; John M. Freeman; Diana J. Pillas; Sumio Uematsu; Benjamin S. Carson; Jason Brandt; Dana Boatman; Margaret B. Pulsifer; Aaron L. Zuckerberg
Pediatrics | 2001
Cheryl Hemingway; John M. Freeman; Diana J. Pillas; Paula L. Pyzik
Archive | 1990
John M. Freeman; Eileen P. G. Vining; Diana J. Pillas
Archive | 2002
John M. Freeman; Eileen P. G. Vining; Diana J. Pillas
Archive | 2012
Jason Brandt; Dana Boatman; Margaret B. Pulsifer; Aaron L. Zuckerberg; P Eileen; G. Vining; John M. Freeman; Diana J. Pillas; Sumio Uematsu